Skip to main content

Paragraph IV Disputes Master Symposium

American Conference Institute


Date: October 2, 2017 - October 3, 2017

Time: 5:00AM - 1:00PM

Location: Chicago, Illinois


  • Ethics Lab for Paragraph IV Practice: Identifying and Avoiding Ethics Pitfalls in Hatch-Waxman Litigation
  • Novartis v. Noven – A Study in Obvious Contrasts: Dilemmas Associated with Different Standards of Review

Event Details

ACI’s industry-leading Paragraph IV Disputes Master Symposium enters its fifth iteration this fall. This event will pick up where ACI Paragraph IV conference left off to bring you up-to-the minute information on the latest developments affecting ANDA litigation.

Preeminent patent litigators representing brand name and generic drug makers, leading in-house counsel, and esteemed jurists will provide insights on such matters as:

  • The impact of TC Heartland on jurisdiction and venue
  • The legal and business repercussions of Helsinn
  • Amgen v. Sandoz from an ANDA litigator’s point of view
  • The FDA Final MMA Rule
  • Novartis v. Noven and differing standards of review
  • Secondary considerations in obviousness reviews
  • Alternative forums: PTAB and ITC
  • Oil States vs. Greene’s Energy Group and the constitutionality of IPR proceedings
  • Exceptional case findings
  • Reverse payment settlements
  • Patent lawsuit risk assessment and other IP due diligence essentials